Remembering B. Smith, Alzheimer’s Advocate and Patient

Eli Lilly and Company  | February 27, 2020

Tags |  Alzheimer's, Science

Earlier this week, the world lost an important advocate for people with Alzheimer’s disease: restauranteur and author B. Smith. 

Smith died after a seven-year battle with Alzheimer’s disease. She was one of the 5.8 million Americans living with Alzheimer’s. 

Smith was diagnosed with early-onset Alzheimer’s in 2013 at the age of 64. After her diagnosis, she opened up about living with the disease, and not being able to remember basic information like the date or year.  

“Things like that make me very sad,” she said on the CBS program “Sunday Morning.” 

But despite her diagnosis, Smith was determined to make a difference and raise awareness about Alzheimer’s, particularly its impact on the African American community.  

Smith collaborated on Before I Forget, a book that shared advice for Alzheimer’s patients and their families. She and her husband, Dan Gasby, also encouraged more African Americans to become involved in Alzheimer’s research and worked to reduce the stigma of an Alzheimer’s diagnosis.

Like Smith, Lilly scientists are determined to make a difference.  

For more than 30 years, Lilly has been engaged in a battle to bring innovative Alzheimer’s disease therapies and diagnostics to patients who need them most.  

Our program is focused on developing disease-modifying therapies that slow clinical progression by targeting the underlying causes of the disease. 

We also continue to lead the field in our research, which includes identifying biomarkers to support early detection of the disease.  

Lilly is honored to be a part of other leading, independent collaborations in the broader Alzheimer’s scientific community.   

We remember Smith and thank her for her dedication and the impact she had on so many people – including others living with Alzheimer’s and their families.